This resolution expresses support for designating September 3, 2026, as "Neuroblastoma Awareness Day" to recognize children and families affected by this rare childhood cancer and to honor the medical professionals and researchers working to treat it. Neuroblastoma is the most common cancer in infants and young children, with 600 to 800 new cases diagnosed annually in the United States, accounting for about 8 to 10 percent of all childhood cancers but roughly 15 percent of childhood cancer deaths. The resolution highlights that high-risk neuroblastoma has a five-year survival rate of approximately 63 percent and often requires intensive treatment including chemotherapy, surgery, radiation, stem cell transplants, and immunotherapy, with survivors frequently facing serious long-term health complications. The resolution notes that childhood cancers historically receive significantly less research funding than adult cancers, and calls attention to the need for continued development of new treatments, including emerging therapies like CAR-T cell treatments. This is a symbolic resolution with no funding or enforcement mechanisms, intended to raise public awareness during September, which is already recognized as Childhood Cancer Awareness Month.